Glycemic Control in Coronary Artery Bypass Graft Surgery: A Different Perspective

Imantalab, Vali; Sedighinejad, Abbas; Jouryabi, Ali Mohammadzadeh; Biazar, Gelareh; Kanani, Gholamreza; Haghighi, Mohammad; Fayazi, Haniyeh Sadat; Ghasvareh, Golnoosh

doi:10.5812/aapm.120073

Cited by 2 publications

(2 citation statements)

References 20 publications

(21 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Larger volumes may increase the risk of local hemodilution. In the literature analysis, the use of cold cardioplegia was described in six patients; one patient was diagnosed with hemolysis (Imantalab et al 2011 ). In other cases, the temperature of the cardioplegia solution was not specified.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Hemolysis during open heart surgery in patients with hereditary spherocytosis — systematic review of the literature and case study

Mendrala,

Czober,

Darocha

et al. 2024

Perioper Med

View full text Add to dashboard Cite

Background Due to the distinctive nature of cardiac surgery, patients suffering from hereditary spherocytosis (HS) are potentially at a high risk of perioperative complications resulting from hemolysis. Despite being the most prevalent cause of hereditary chronic hemolysis, the standards of surgical management are based solely on expert opinion. Objective We analyze the risk of hemolysis in HS patients after cardiac surgery based on a systematic review of the literature. We also describe a case of a patient with hereditary spherocytosis who underwent aortic valve repair. Methods This systematic review was registered in the PROSPERO international prospective register of systematic reviews (CRD42023417666) and included records from Embase, MEDLINE, Web of Science, and Google Scholar databases. The case study investigates a 38-year-old patient who underwent surgery for an aortic valve defect in mid-2022. Results Of the 787 search results, 21 studies describing 23 cases of HS undergoing cardiac surgery were included in the final analysis. Hemolysis was diagnosed in five patients (one coronary artery bypass graft surgery, two aortic valve bioprosthesis, one ventricular septal defect closure, and one mitral valve plasty). None of the patients died in the perioperative period. Also, no significant clinical hemolysis was observed in our patient during the perioperative period. Conclusions The literature data show that hemolysis is not common in patients with HS undergoing various cardiac surgery techniques. The typical management of a patient with mild/moderate HS does not appear to increase the risk of significant clinical hemolysis. Commonly accepted beliefs about factors inducing hemolysis during cardiac surgery may not be fully justified and require further investigation.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Also, ultrafiltration reduces hemodilution. In the systematic review, the use of renal replacement therapy (RRT) has been described in four patients, only one with hemolysis (Imantalab et al 2011 ).…”

Section: Discussionmentioning

confidence: 99%

Hemolysis during open heart surgery in patients with hereditary spherocytosis — systematic review of the literature and case study

Mendrala,

Czober,

Darocha

et al. 2024

Perioper Med

View full text Add to dashboard Cite

show abstract

7-year outcomes in diabetic patients after coronary artery bypass graft in a developing country

Pezeshki

Masoudkabir

Pashang

et al. 2023

BMC Cardiovasc Disord

View full text Add to dashboard Cite

Background Revascularization in diabetic patients with coronary artery disease remains a challenge in cardiology practice. Although clinical trials have reported the mid-term superiority of coronary artery bypass grafting (CABG) surgery over percutaneous coronary intervention in these patients, little is known about the long-term outcomes of CABG in diabetic patients compared to non-diabetics, particularly in developing countries. Methods Between 2007 and 2016, we recruited all patients who underwent isolated CABG in a tertiary care cardiovascular center in a developing country. The patients were followed at 3–6 months and 12 months after surgery, and then annually. The study endpoints were 7-year all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE). Results Of 23,873 patients (17,529 males, mean age 65.67 years) who underwent CABG, 9227 (38.65%) patients were diagnosed with diabetes. After adjustment for potential confounders, patients with diabetes experienced a 31% increase in MACCE seven years after surgery compared to the non-diabetic patients (HR = 1.31, 95% CI: 1.25–1.38, P-value < 0.0001). Meanwhile, diabetes contributes to a 52% increase in the risk of all-cause mortality after CABG (HR = 1.52, 95% CI: 1.42–1.61, P-value < 0.0001). Conclusions Our study showed a higher risk of all-cause mortality and MACCE at seven years in diabetic patients undergoing isolated CABG. The outcomes in the studied center in a developing country were comparable to western centers. The high incidence of adverse outcomes in the long term in diabetic patients implies that not only short-term but long-term measures should be taken to improve the CABG outcomes in this challenging patient population.

show abstract

Glycemic Control in Coronary Artery Bypass Graft Surgery: A Different Perspective

Cited by 2 publications

References 20 publications

Hemolysis during open heart surgery in patients with hereditary spherocytosis — systematic review of the literature and case study

Hemolysis during open heart surgery in patients with hereditary spherocytosis — systematic review of the literature and case study

7-year outcomes in diabetic patients after coronary artery bypass graft in a developing country

Contact Info

Product

Resources

About